Both in Pharmaceuticals
Ardelyx vs MoonLake Immunotherapeutics
Over the past year ARDX returned −39.5% and MLTX returned −3.1%; their daily moves had a correlation of 0.36.
ARDX −39.5% MLTX −3.1%Growth of $1, one year, split-adjusted
| Metric | ARDX | MLTX |
|---|---|---|
| Price | $3.11 | $9.59 |
| Market cap | $801.7M | $815.7M |
| Today | −5.05% | −6.58% |
| 1 month | −8.1% | −22.4% |
| 6 months | −51.9% | −47.7% |
| Year to date | −46.7% | −27.3% |
| 1 year | −39.5% | −3.1% |
| Revenue growth (YoY) | +23.8% | — |
| Gross margin | 95.2% | — |
| Net margin | −13.8% | — |
| P/E (TTM) | — | — |
| Price / sales | 1.8× | — |
| Net cash | $30.0M | $437.5M |
| Dividend yield | — | — |
| Volatility (60d) | 49.5% | 47.7% |
| Short % of float | 11.4% | 13.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).